Yannick Cerantola

Jewish General Hospital, University Hospital of Lausanne

Papers

Total Citations

H-Index

About

Yannick Cerantola is a urologic surgeon and researcher whose work centers on improving the precision and outcomes of surgical interventions for prostate and kidney cancers. His most-cited study, "Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest" (2015, 17 citations), made a pivotal contribution to the field of targeted prostate biopsy. This work demonstrated the reliability of cognitive fusion—where the surgeon mentally registers MRI findings during ultrasound-guided biopsy—showing that this low-tech, cost-effective approach can accurately hit suspicious lesions identified on multiparametric MRI. The study helped validate cognitive targeting as a viable alternative to more expensive software-based fusion systems, influencing clinical practice in centers with limited resources. Cerantola also investigated the learning curve and safety of robotic partial nephrectomy, asking whether teaching this complex procedure to trainees compromises patient outcomes. His findings on perioperative safety and renal function preservation provided reassurance for training programs adopting robotic surgery. Though his citation counts are modest, Cerantola’s research addresses practical, high-impact questions in urologic oncology, bridging the gap between advanced imaging and everyday surgical decision-making.